Comparison of the prophylactic antithrombotic effect of indobufen and warfarin in patients with nephrotic syndrome: a randomized controlled trial

PURPOSE: The risk of thromboembolic events is elevated in patients with nephrotic syndrome, and warfarin use has been associated with an increased risk of bleeding. Indobufen, a selective cyclooxygenase-1 inhibitor, is currently being evaluated for the prevention of thromboembolic events in nephroti...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xin-Yi, Liu, Yue-Ming, Zheng, Dan-Na, Li, Yi-Wen, Li, Hua, Xiong, Xiao-Ling, Chen, Hong-Yu, Wang, Hua, Yu, Xiao-Yong, Qu, Kai, Jin, Juan, Lin, Bo, He, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848225/
https://www.ncbi.nlm.nih.gov/pubmed/36636998
http://dx.doi.org/10.1080/0886022X.2022.2163505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848225/
https://www.ncbi.nlm.nih.gov/pubmed/36636998
http://dx.doi.org/10.1080/0886022X.2022.2163505

Ejemplares similares